Last reviewed · How we verify

peribulbar block 1 lidocaine/bupivacaine

Centro Medico Docente la Trinidad · Phase 3 active Small molecule

peribulbar block 1 lidocaine/bupivacaine is a Local anesthetic Small molecule drug developed by Centro Medico Docente la Trinidad. It is currently in Phase 3 development for Peribulbar block for ophthalmic surgery. Also known as: lidocaine/bupivacaine.

Lidocaine and bupivacaine work by blocking sodium channels in nerve fibers, preventing the transmission of pain signals.

Lidocaine and bupivacaine work by blocking sodium channels in nerve fibers, preventing the transmission of pain signals. Used for Peribulbar block for ophthalmic surgery.

At a glance

Generic nameperibulbar block 1 lidocaine/bupivacaine
Also known aslidocaine/bupivacaine
SponsorCentro Medico Docente la Trinidad
Drug classLocal anesthetic
TargetVoltage-gated sodium channels
ModalitySmall molecule
Therapeutic areaAnesthesiology
PhasePhase 3

Mechanism of action

Lidocaine and bupivacaine are both local anesthetics that act by inhibiting the influx of sodium ions into nerve cells, which is necessary for the initiation and transmission of nerve impulses. This results in a temporary loss of sensation in the area where the anesthetic is administered.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about peribulbar block 1 lidocaine/bupivacaine

What is peribulbar block 1 lidocaine/bupivacaine?

peribulbar block 1 lidocaine/bupivacaine is a Local anesthetic drug developed by Centro Medico Docente la Trinidad, indicated for Peribulbar block for ophthalmic surgery.

How does peribulbar block 1 lidocaine/bupivacaine work?

Lidocaine and bupivacaine work by blocking sodium channels in nerve fibers, preventing the transmission of pain signals.

What is peribulbar block 1 lidocaine/bupivacaine used for?

peribulbar block 1 lidocaine/bupivacaine is indicated for Peribulbar block for ophthalmic surgery.

Who makes peribulbar block 1 lidocaine/bupivacaine?

peribulbar block 1 lidocaine/bupivacaine is developed by Centro Medico Docente la Trinidad (see full Centro Medico Docente la Trinidad pipeline at /company/centro-medico-docente-la-trinidad).

Is peribulbar block 1 lidocaine/bupivacaine also known as anything else?

peribulbar block 1 lidocaine/bupivacaine is also known as lidocaine/bupivacaine.

What drug class is peribulbar block 1 lidocaine/bupivacaine in?

peribulbar block 1 lidocaine/bupivacaine belongs to the Local anesthetic class. See all Local anesthetic drugs at /class/local-anesthetic.

What development phase is peribulbar block 1 lidocaine/bupivacaine in?

peribulbar block 1 lidocaine/bupivacaine is in Phase 3.

What are the side effects of peribulbar block 1 lidocaine/bupivacaine?

Common side effects of peribulbar block 1 lidocaine/bupivacaine include Cardiovascular effects (e.g. hypotension, bradycardia), Central nervous system effects (e.g. seizures, respiratory depression).

What does peribulbar block 1 lidocaine/bupivacaine target?

peribulbar block 1 lidocaine/bupivacaine targets Voltage-gated sodium channels and is a Local anesthetic.

Related